44 related articles for article (PubMed ID: 30904670)
41. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
[TBL] [Abstract][Full Text] [Related]
42. Iron Dysregulation in Parkinson's Disease: Focused on the Autophagy-Lysosome Pathway.
Chen LL; Huang YJ; Cui JT; Song N; Xie J
ACS Chem Neurosci; 2019 Feb; 10(2):863-871. PubMed ID: 30590010
[TBL] [Abstract][Full Text] [Related]
43. Parkinson's disease: experimental models and reality.
Jiang P; Dickson DW
Acta Neuropathol; 2018 Jan; 135(1):13-32. PubMed ID: 29151169
[TBL] [Abstract][Full Text] [Related]
44. Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications.
Moloughney JG; Weisleder N
Recent Pat Biotechnol; 2012 Dec; 6(3):200-11. PubMed ID: 23092436
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
